Amicogen, Inc. (KOSDAQ: A092040)
Health Care · Biotechnology · KR
₩1,000.00
+3.09% today · -70.2% 1Y
Amicogen, Inc. (KOSDAQ: A092040) operates in the Biotechnology industry within the Health Care sector. The company is valued at $50.84M.
Over the last twelve months the share price has lost 70.2%, trading between 926.00 and 4.40K.
Tweenvest scores Amicogen, Inc. across four factors: quality 38/100, value 64/100. Its strongest factor is value.
A092040 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $50.84M
- Revenue (TTM)
- $28.54M
- P/E
- —
- EPS
- -79.78
- Dividend yield
- —
- Beta (5Y)
- 0.18
- 52-week high
- ₩4,400.00
- 52-week low
- ₩926.00
- Avg volume (3M)
- —
- Shares outstanding
- 70.45M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.80 | +0.00% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $444.00 | +0.40% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.10 | -0.45% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $551.33 | -0.27% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $832.63 | -0.11% |
| argenx SEENXTBR: ARGX | $64.17B | €903.40 | +2.75% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $155.51 | -2.09% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.